Germinal Center-Related G Protein-Coupled Receptors in Antibody-Mediated Autoimmune Skin Diseases: from Basic Research to Clinical Trials

Lee A, Bannan JL, Adams MJ et al (2017) Expression of CCR6 on B cells in systemic lupus erythematosus patients[J]. Clin Rheumatol 36(6):1453–1456

PubMed  Article  Google Scholar 

Demoor T, Bracke KR, Maes T et al (2009) Role of lymphotoxin-alpha in cigarette smoke-induced inflammation and lymphoid neogenesis[J]. Eur Respir J 34(2):405–416

CAS  PubMed  Article  Google Scholar 

Anderson MW, Zhao S, Ai WZ et al (2010) C-C chemokine receptor 1 expression in human hematolymphoid neoplasia[J]. Am J Clin Pathol 133(3):473–483

PubMed  Article  Google Scholar 

Hauser AS, Chavali S, Masuho I et al (2018) Pharmacogenomics of GPCR Drug Targets[J]. Cell 172(1–2):41–54

CAS  PubMed  PubMed Central  Article  Google Scholar 

Koscielny G, An P, Carvalho-Silva D et al (2017) Open Targets: a platform for therapeutic target identification and validation[J]. Nucleic Acids Res 45(D1):D985–D994

CAS  PubMed  Article  Google Scholar 

Cabral-Marques O, Marques A, Giil LM et al (2018) GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis[J]. Nat Commun 9(1):5224

CAS  PubMed  PubMed Central  Article  Google Scholar 

Groves A, Kihara Y, Jonnalagadda D et al (2018) A functionally defined in vivo astrocyte population identified by c-Fos activation in a mouse model of multiple sclerosis modulated by S1P signaling: immediate-early astrocytes (ieAstrocytes)[J]. eNeuro 5(5)

Li E, Shan H, Chen L et al (2019) OLFR734 Mediates glucose metabolism as a receptor of asprosin[J]. Cell Metab 30(2):319–328

CAS  PubMed  Article  Google Scholar 

Sharma G, Hu C, Staquicini DI et al (2020) Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes[J]. Sci Transl Med 12(528)

Palacios JM, Pazos A, Hoyer D (2017) A short history of the 5-HT(2C) receptor: from the choroid plexus to depression, obesity and addiction treatment[J]. Psychopharmacology 234(9–10):1395–1418

CAS  PubMed  Article  Google Scholar 

Yempala T, Brea J, Loza MI et al (2020) Dibenzofuranylethylamines as 5-HT(2A/2C) receptor agonists[J]. ACS Omega 5(5):2260–2266

CAS  PubMed  PubMed Central  Article  Google Scholar 

Chang W, Tu CL, Jean-Alphonse FG et al (2020) PTH hypersecretion triggered by a GABA(B1) and Ca(2+)-sensing receptor heterocomplex in hyperparathyroidism[J]. Nat Metab 2(3):243–255

CAS  PubMed  PubMed Central  Article  Google Scholar 

Abdel-Magid AF (2019) Treatment of diabetes, obesity, dyslipidemia, and related disorders with GPR119 agonists[J]. ACS Med Chem Lett 10(1):14–15

CAS  PubMed  Article  Google Scholar 

Celorrio M, Rojo-Bustamante E, Fernández-Suárez D et al (2017) GPR55: a therapeutic target for Parkinson’s disease?[J]. Neuropharmacology 125:319–332

CAS  PubMed  Article  Google Scholar 

Planell N, Masamunt MC, Leal RF et al (2017) Usefulness of transcriptional blood biomarkers as a non-invasive surrogate marker of mucosal healing and endoscopic response in ulcerative colitis[J]. J Crohns Colitis 11(11):1335–1346

PubMed  PubMed Central  Article  Google Scholar 

Griffith JW, Sokol CL, Luster AD (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity[J]. Annu Rev Immunol 32:659–702

CAS  PubMed  Article  Google Scholar 

Schulz O, Hammerschmidt SI, Moschovakis GL et al (2016) Chemokines and chemokine receptors in lymphoid tissue dynamics[J]. Annu Rev Immunol 34:203–242

CAS  PubMed  Article  Google Scholar 

Friedman SL, Ratziu V, Harrison SA et al (2018) A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis[J]. Hepatology 67(5):1754–1767

CAS  PubMed  Article  Google Scholar 

Sato T, Coler-Reilly A, Yagishita N et al (2018) Mogamulizumab (anti-CCR4) in HTLV-1-associated myelopathy[J]. N Engl J Med 378(6):529–538

CAS  PubMed  Article  Google Scholar 

Kim YH, Bagot M, Pinter-Brown L et al (2018) Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial[J]. Lancet Oncol 19(9):1192–1204

CAS  PubMed  Article  Google Scholar 

Schott AF, Goldstein LJ, Cristofanilli M et al (2017) Phase Ib Pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2-negative metastatic breast cancer[J]. Clin Cancer Res 23(18):5358–5365

CAS  PubMed  PubMed Central  Article  Google Scholar 

Nakajima C, Mukai T, Yamaguchi N et al (2002) Induction of the chemokine receptor CXCR3 on TCR-stimulated T cells: dependence on the release from persistent TCR-triggering and requirement for IFN-gamma stimulation[J]. Eur J Immunol 32(6):1792–1801

CAS  PubMed  Article  Google Scholar 

Groom JR, Richmond J, Murooka TT et al (2012) CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation[J]. Immunity 37(6):1091–1103

CAS  PubMed  PubMed Central  Article  Google Scholar 

Campbell DJ, Kim CH, Butcher EC (2001) Separable effector T cell populations specialized for B cell help or tissue inflammation[J]. Nat Immunol 2(9):876–881

CAS  PubMed  Article  Google Scholar 

Shi J, Hou S, Fang Q et al (2018) PD-1 Controls follicular T helper cell positioning and function[J]. Immunity 49(2):264–274

CAS  PubMed  PubMed Central  Article  Google Scholar 

Turpin D, Furudoi A, Parrens M et al (2018) Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications[J]. Clin Immunol 197:130–138

Bier J, Rao G, Payne K et al (2019) Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4(+) T cells[J]. J Allergy Clin Immunol 144(1):236–253

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ottaviano G, Gerosa J, Santini M et al (2020) A prevalent CXCR3(+) phenotype of circulating follicular helper T cells indicates humoral dysregulation in children with Down Syndrome[J]. J Clin Immunol 40(3):447–455

CAS  PubMed  Article  Google Scholar 

Kawaguchi N, Zhang TT, Nakanishi T (2019) Involvement of CXCR4 in normal and abnormal development[J]. Cells 8(2)

Allen CD, Ansel KM, Low C et al (2004) Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5[J]. Nat Immunol 5(9):943–952

CAS  PubMed  Article  Google Scholar 

Weber TS (2018) Cell cycle-associated CXCR4 expression in germinal center B cells and its implications on affinity maturation[J]. Front Immunol 9:1313

PubMed  PubMed Central  Article  CAS  Google Scholar 

Pak HK, Nam B, Lee YK et al (2018) Human plasmablast migration toward CXCL12 requires glucose oxidation by enhanced pyruvate dehydrogenase activity via AKT[J]. Front Immunol 9:1742

PubMed  PubMed Central  Article  CAS  Google Scholar 

Jandl C, Liu SM, Cañete PF et al (2017) IL-21 restricts T follicular regulatory T cell proliferation through Bcl-6 mediated inhibition of responsiveness to IL-2[J]. Nat Commun 8:14647

CAS  PubMed  PubMed Central  Article  Google Scholar 

Unger PA, Lighaam LC, Vermeulen E et al (2020) Divergent chemokine receptor expression and the consequence for human IgG4 B cell responses[J]. Eur J Immunol

Vanderleyden I, Fra-Bido SC, Innocentin S et al (2020) Follicular regulatory T cells can access the germinal center independently of CXCR5[J]. Cell Rep 30(3):611–619

CAS  PubMed  PubMed Central  Article  Google Scholar 

Shen E, Rabe H, Luo L et al (2019) Control of germinal center localization and lineage stability of follicular regulatory T cells by the Blimp1 transcription factor[J]. Cell Rep 29(7):1848–1861

PubMed  PubMed Central  Article  CAS  Google Scholar 

Denton AE, Innocentin S, Carr EJ et al (2019) Type I interferon induces CXCL13 to support ectopic germinal center formation[J]. J Exp Med 216(3):621–637

CAS  PubMed  PubMed Central  Article  Google Scholar 

Chen Y, Yu M, Zheng Y et al (2019) CXCR5(+)PD-1(+) follicular helper CD8 T cells control B cell tolerance[J]. Nat Commun 10(1):4415

PubMed  PubMed Central  Article  CAS  Google Scholar 

Moschovakis GL, Bubke A, Friedrichsen M et al (2017) T cell specific Cxcr5 deficiency prevents rheumatoid arthritis[J]. Sci Rep 7(1):8933

PubMed  PubMed Central  Article  CAS  Google Scholar 

Gu-Trantien C, Migliori E, Buisseret L et al (2017) CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer[J]. JCI Insight 2(11)

Wang C, Chen W, Shen J (2018) CXCR7 targeting and its major disease relevance[J]. Front Pharmacol 9:641

PubMed  PubMed Central  Article  CAS  Google Scholar 

Tarnowski M, Liu R, Wysoczynski M et al (2010) CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells[J]. Eur J Haematol 85(6):472–483

留言 (0)

沒有登入
gif